InspireMD, Inc. (NSPR) vs Rein Therapeutics Inc. (RNTX)

A side-by-side comparison of InspireMD, Inc. and Rein Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

NSPR

InspireMD, Inc.

$25M

$0.53HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

RNTX

Rein Therapeutics Inc.

$23M

$0.83HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — NSPR vs RNTX

growth of $100 · dividends reinvested · last 2y

NSPR -87.5% (-64.6%/yr)RNTX -61.1% (-37.6%/yr)RNTX compounded faster over this window

NSPR RNTX

NSPR vs RNTX: by the numbers

•NSPR is the larger company ($25M vs $23M market cap).
•Both run net losses; RNTX's is the smaller (0.00% vs -355.17% net margin).

Metrics side by side

Valuation

Metric	NSPR	RNTX
P/S ratio	2.27	N/A
P/B ratio	0.78	2.26

Profitability

Metric	NSPR	RNTX
Gross margin	29.50%	0.00%
Operating margin	-546.97%	0.00%
Net margin	-355.17%	0.00%
ROE	-122.19%	-487.90%
ROIC	-153.04%	-36.89%

Growth (annualized)

Metric	NSPR	RNTX
Revenue CAGR (5Y)	27.79%	N/A
Total return CAGR (5Y)	-36.91%	N/A

Go deeper

Full NSPR analysis Full RNTX analysis Interactive comparison tool

Dig into the metrics

InspireMD ROE Rein Therapeutics ROE InspireMD operating margin Rein Therapeutics operating margin InspireMD revenue growth Rein Therapeutics revenue growth InspireMD free cash flow Rein Therapeutics free cash flow

InspireMD & Rein Therapeutics appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.